D. Paul Harkin
Impact in
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- Cancer-related Molecular Pathways
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
Papers in
- Co-authors
- Patrick G. Johnston (6 shared papers)Daniel B. Longley (1 shared paper)Paul B. Mullan (7 shared papers)Richard D. Kennedy (7 shared papers)Jennifer E. Quinn (5 shared papers)Daniel A. Haber (5 shared papers)J. E. Quinn (4 shared papers)Paula M. Gilmore (4 shared papers)
- Journals
- Breast Cancer Research (2 papers)Proceedings of the National Academy of Sciences (2 papers)Cancer (2 papers)Clinical Cancer Research (2 papers)Biochemical Society Transactions (2 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
D. Paul Harkin
23 papers receiving 6.6k citations
D. Paul Harkin's Hit Papers
Peers
Comparison fields: 5 of 141
- Oncology 2.4k
- Cancer Research 1.1k
- Molecular Biology 2.9k
- Pathology and Forensic Medicine 541
- Immunology 574
Countries citing papers authored by D. Paul Harkin
This map shows the geographic impact of D. Paul Harkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Paul Harkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Paul Harkin more than expected).
Fields of papers citing papers by D. Paul Harkin
This network shows the impact of papers produced by D. Paul Harkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Paul Harkin. The network helps show where D. Paul Harkin may publish in the future.
Co-authors
The 25 scholars most cited alongside D. Paul Harkin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 5-Fluorouracil: mechanisms of action and clinical strategies Hit paper breakdown → | 2003 | 4326 |
| 2 | 1998 | 447 | |
| 3 | 2004 | 363 | |
| 4 | BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis. | 2003 | 350 |
| 5 | 1997 | 297 | |
| 6 | 2007 | 180 | |
| 7 | 1996 | 174 | |
| 8 | 2011 | 155 | |
| 9 | 2007 | 135 | |
| 10 | 2006 | 111 | |
| 11 | 2005 | 44 | |
| 12 | 2019 | 31 | |
| 13 | 2022 | 29 | |
| 14 | 2014 | 26 | |
| 15 | 2017 | 23 | |
| 16 | 2001 | 14 | |
| 17 | 1996 | 13 | |
| 18 | 2001 | 12 | |
| 19 | 2010 | 3 | |
| 20 | DNA damage response deficiency signature predicts response to platinum-based therapy in ovarian cancer | 2013 | 3 |
About D. Paul Harkin
D. Paul Harkin is a scholar working on Oncology, Genetics, Molecular Biology, Pathology and Forensic Medicine and Cancer Research, having authored 23 papers that have together received 6.7k indexed citations. Recurring topics across this work include Gene expression and cancer classification (6 papers), BRCA gene mutations in cancer (6 papers), DNA Repair Mechanisms (4 papers), CRISPR and Genetic Engineering (3 papers), Animal Genetics and Reproduction (2 papers), Genomic variations and chromosomal abnormalities (2 papers), Viral-associated cancers and disorders (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Oncology (2.4k citations), Cancer Research (1.1k citations), Molecular Biology (2.9k citations), Pathology and Forensic Medicine (541 citations) and Immunology (574 citations). D. Paul Harkin has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Patrick G. Johnston, Daniel B. Longley, Paul B. Mullan, Richard D. Kennedy, Jennifer E. Quinn, Daniel A. Haber, J. E. Quinn, Paula M. Gilmore, Michael Carty and Kurt J. Isselbacher. Their work appears in journals such as Breast Cancer Research, Proceedings of the National Academy of Sciences, Cancer, Clinical Cancer Research and Biochemical Society Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.